Pineapple Express Cannabis (PNXP) Notes Payables (2020 - 2025)

Pineapple Express Cannabis' (PNXP) quarterly Notes Payables came in at $3.7 million in Q4 2025, little changed quarter-over-quarter from $3.7 million in Q3 2025.

Pineapple Express Cannabis (PNXP) Notes Payables (2020 - 2025) Analysis & Trends

Pineapple Express Cannabis has disclosed Notes Payables across 2 years of filings, most recently posting $3.7 million for Q4 2025.

  • Notes Payables for Q4 2025 came in at $3.7 million, changed N/A year-over-year; the trailing twelve-month figure through Oct 2025 was $3.7 million (changed N/A YoY), and the FY2020 annual result was $7530.0, changed N/A from the prior year.
  • Notes Payables came in at $3.7 million for Q4 2025 at Pineapple Express Cannabis, roughly flat from $3.7 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $3.7 million in Q3 2025 to a low of $3.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Pineapple Express Cannabis - - -

Historic Data

Download Data
DateValue
Oct 31, 2025 3.72 Mn
Jul 31, 2025 3.73 Mn
Apr 30, 2025 3.72 Mn
Jan 31, 2020 7,530.00